Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma

Figure 2 Shuyu pills inhibited the growth of hepatocellular carcinoma in vivo. The xenograft mouse model was established in BALB/c nude mice that were then randomly divided into four groups (n = 6): Control group (0.9% normal saline, daily), Shuyu pills (SYP) (200 mg/kg, daily), Cisplatin (DDP) (5 mg/kg, once a week), and SYP (200 mg/kg, daily) + DDP (5 mg/kg, once a week). The body weight of each mouse and the tumor volume were measured every 2 d, with the latter calculated as follows: Maximum tumor length × width (2 × 0.5). A: Representative images of the tumors at the end of treatment; B: Average tumor volumes, measured every 2 d; C: Tumor weights at the end of treatment; D: Average body weights of the mice, measured every 2 d. ^bP < 0.01 vs Control group; ^dP < 0.01 vs SYP group; ^fP < 0.01 vs SYP + DDP group. SYP: Shuyu pills; DDP: Cisplatin.